Podcasts about Eifert

En este episodio abordo la farmacología en neurorrehabilitación del adulto desde una perspectiva clínica y realista, pensada especialmente para profesionales no médicos que conviven a diario con informes, pautas y nombres de fármacos sin disponer siempre de un marco claro para interpretarlos. Recorremos los principales medicamentos utilizados en patologías neurológicas frecuentes —ictus, lesión medular, esclerosis múltiple, enfermedad de Parkinson, ELA, distonías y traumatismo craneoencefálico— diferenciando entre tratamientos agudos, terapias modificadoras de la enfermedad y manejo farmacológico de secuelas. A lo largo del episodio explico de forma progresiva los mecanismos de acción, la base neurofisiológica y el estado actual de la evidencia, poniendo especial énfasis en qué fármacos realmente cambian el pronóstico y cuáles cumplen un papel fundamentalmente sintomático. El objetivo no es prescribir, sino entender mejor cómo la farmacología condiciona la recuperación, la participación en terapia y la toma de decisiones en neurorrehabilitación, con una mirada crítica y basada en la evidencia disponible. Referencias del episodio: 1.     Adams, M. M., & Hicks, A. L. (2005). Spasticity after spinal cord injury. Spinal cord, 43(10), 577–586. https://doi.org/10.1038/sj.sc.3101757 (https://pubmed.ncbi.nlm.nih.gov/15838527/). 2.     AFFINITY Trial Collaboration (2020). Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology, 19(8), 651–660. https://doi.org/10.1016/S1474-4422(20)30207-6 (https://pubmed.ncbi.nlm.nih.gov/32702334/). 3.     Angeli, C. A., Edgerton, V. R., Gerasimenko, Y. P., & Harkema, S. J. (2014). Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in humans. Brain : a journal of neurology, 137(Pt 5), 1394–1409. https://doi.org/10.1093/brain/awu038 (https://pubmed.ncbi.nlm.nih.gov/24713270/). 4.     Bracken, M. B., Shepard, M. J., Collins, W. F., Holford, T. R., Young, W., Baskin, D. S., Eisenberg, H. M., Flamm, E., Leo-Summers, L., & Maroon, J. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. The New England journal of medicine, 322(20), 1405–1411. https://doi.org/10.1056/NEJM199005173222001 (https://pubmed.ncbi.nlm.nih.gov/2278545/). 5.     Bracken, M. B., Shepard, M. J., Holford, T. R., Leo-Summers, L., Aldrich, E. F., Fazl, M., Fehlings, M., Herr, D. L., Hitchon, P. W., Marshall, L. F., Nockels, R. P., Pascale, V., Perot, P. L., Jr, Piepmeier, J., Sonntag, V. K., Wagner, F., Wilberger, J. E., Winn, H. R., & Young, W. (1997). Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA, 277(20), 1597–1604 (https://pubmed.ncbi.nlm.nih.gov/9168289/). 6.     Cardenas, D. D., Ditunno, J. F., Graziani, V., McLain, A. B., Lammertse, D. P., Potter, P. J., Alexander, M. S., Cohen, R., & Blight, A. R. (2014). Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury. Spinal cord, 52(1), 70–76. https://doi.org/10.1038/sc.2013.137 (https://pubmed.ncbi.nlm.nih.gov/24216616/). 7.     Chollet, F., Tardy, J., Albucher, J. F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., Guillon, B., Moulin, T., Marque, P., Pariente, J., Arnaud, C., & Loubinoux, I. (2011). Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. The Lancet. Neurology, 10(2), 123–130. https://doi.org/10.1016/S1474-4422(10)70314-8 (https://pubmed.ncbi.nlm.nih.gov/21216670/). 8.     Dávalos, A., Alvarez-Sabín, J., Castillo, J., Díez-Tejedor, E., Ferro, J., Martínez-Vila, E., Serena, J., Segura, T., Cruz, V. T., Masjuan, J., Cobo, E., Secades, J. J., & International Citicoline Trial on acUte Stroke (ICTUS) trial investigators (2012). Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet (London, England), 380(9839), 349–357. https://doi.org/10.1016/S0140-6736(12)60813-7 (https://pubmed.ncbi.nlm.nih.gov/22691567/). 9.     EFFECTS Trial Collaboration (2020). Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology, 19(8), 661–669. https://doi.org/10.1016/S1474-4422(20)30219-2 (https://pubmed.ncbi.nlm.nih.gov/32702335/). 10.  Fehlings, M. G., Theodore, N., Harrop, J., Maurais, G., Kuntz, C., Shaffrey, C. I., Kwon, B. K., Chapman, J., Yee, A., Tighe, A., & McKerracher, L. (2011). A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. Journal of neurotrauma, 28(5), 787–796. https://doi.org/10.1089/neu.2011.1765 (https://pubmed.ncbi.nlm.nih.gov/21381984/). 11.  FOCUS Trial Collaboration (2019). Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet (London, England), 393(10168), 265–274. https://doi.org/10.1016/S0140-6736(18)32823-X (https://pubmed.ncbi.nlm.nih.gov/30528472/). 12.  Forgione, N., & Fehlings, M. G. (2014). Rho-ROCK inhibition in the treatment of spinal cord injury. World neurosurgery, 82(3-4), e535–e539. https://doi.org/10.1016/j.wneu.2013.01.009 (http://pubmed.ncbi.nlm.nih.gov/23298675/). 13.  Fournier, A. E., Takizawa, B. T., & Strittmatter, S. M. (2003). Rho kinase inhibition enhances axonal regeneration in the injured CNS. The Journal of neuroscience : the official journal of the Society for Neuroscience, 23(4), 1416–1423. https://doi.org/10.1523/JNEUROSCI.23-04-01416.2003 (https://pubmed.ncbi.nlm.nih.gov/12598630/). 14.  Giacino, J. T., Whyte, J., Bagiella, E., Kalmar, K., Childs, N., Khademi, A., Eifert, B., Long, D., Katz, D. I., Cho, S., Yablon, S. A., Luther, M., Hammond, F. M., Nordenbo, A., Novak, P., Mercer, W., Maurer-Karattup, P., & Sherer, M. (2012). Placebo-controlled trial of amantadine for severe traumatic brain injury. The New England journal of medicine, 366(9), 819–826. https://doi.org/10.1056/NEJMoa1102609 (https://pubmed.ncbi.nlm.nih.gov/22375973/). 15.  Goodman, A. D., Brown, T. R., Krupp, L. B., Schapiro, R. T., Schwid, S. R., Cohen, R., Marinucci, L. N., Blight, A. R., & Fampridine MS-F203 Investigators (2009). Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet (London, England), 373(9665), 732–738. https://doi.org/10.1016/S0140-6736(09)60442-6 (https://pubmed.ncbi.nlm.nih.gov/19249634/). 16.  Goodman, A. D., Brown, T. R., Edwards, K. R., Krupp, L. B., Schapiro, R. T., Cohen, R., Marinucci, L. N., Blight, A. R., & MSF204 Investigators (2010). A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Annals of neurology, 68(4), 494–502. https://doi.org/10.1002/ana.22240 (https://pubmed.ncbi.nlm.nih.gov/20976768/). 17.  Hurlbert, R. J., Hadley, M. N., Walters, B. C., Aarabi, B., Dhall, S. S., Gelb, D. E., Rozzelle, C. J., Ryken, T. C., & Theodore, N. (2013). Pharmacological therapy for acute spinal cord injury. Neurosurgery, 72 Suppl 2, 93–105. https://doi.org/10.1227/NEU.0b013e31827765c6 (https://pubmed.ncbi.nlm.nih.gov/23417182/). 18.  Johnston, S. C., Amarenco, P., Denison, H., Evans, S. R., Himmelmann, A., James, S., Knutsson, M., Ladenvall, P., Molina, C. A., Wang, Y., & THALES Investigators (2020). Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. The New England journal of medicine, 383(3), 207–217. https://doi.org/10.1056/NEJMoa1916870 (https://pubmed.ncbi.nlm.nih.gov/32668111/). 19.  Kheder, A., & Nair, K. P. (2012). Spasticity: pathophysiology, evaluation and management. Practical neurology, 12(5), 289–298. https://doi.org/10.1136/practneurol-2011-000155 (https://pubmed.ncbi.nlm.nih.gov/22976059/). 20.  Kirkman, M. A., Day, J., Gehring, K., Zienius, K., Grosshans, D., Taphoorn, M., Li, J., & Brown, P. D. (2022). Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. The Cochrane database of systematic reviews, 11(11), CD011335. https://doi.org/10.1002/14651858.CD011335.pub3 (https://pubmed.ncbi.nlm.nih.gov/36427235/). 21.  Martinsson L, Hårdemark H, Eksborg S. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002090. doi: 10.1002/14651858.CD002090.pub2. PMID: 17253474; PMCID: PMC12278358 (https://pubmed.ncbi.nlm.nih.gov/17253474/). 22.  Miller, T. M., Cudkowicz, M. E., Genge, A., Shaw, P. J., Sobue, G., Bucelli, R. C., Chiò, A., Van Damme, P., Ludolph, A. C., Glass, J. D., Andrews, J. A., Babu, S., Benatar, M., McDermott, C. J., Cochrane, T., Chary, S., Chew, S., Zhu, H., Wu, F., Nestorov, I., … VALOR and OLE Working Group (2022). Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. The New England journal of medicine, 387(12), 1099–1110. https://doi.org/10.1056/NEJMoa2204705 (https://pubmed.ncbi.nlm.nih.gov/36129998/). 23.  Mueller, B. K., Mack, H., & Teusch, N. (2005). Rho kinase, a promising drug target for neurological disorders. Nature reviews. Drug discovery, 4(5), 387–398. https://doi.org/10.1038/nrd1719 (https://pubmed.ncbi.nlm.nih.gov/15864268/). 24.  Nourbakhsh, B., Revirajan, N., & Waubant, E. (2018). Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial. Contemporary clinical trials, 64, 67–76. https://doi.org/10.1016/j.cct.2017.11.005 (https://pubmed.ncbi.nlm.nih.gov/29113955/). 25.  Paganoni, S., Hendrix, S., Dickson, S. P., Knowlton, N., Macklin, E. A., Berry, J. D., Elliott, M. A., Maiser, S., Karam, C., Caress, J. B., Owegi, M. A., Quick, A., Wymer, J., Goutman, S. A., Heitzman, D., Heiman-Patterson, T. D., Jackson, C. E., Quinn, C., Rothstein, J. D., Kasarskis, E. J., … Cudkowicz, M. E. (2021). Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis. Muscle & nerve, 63(1), 31–39. https://doi.org/10.1002/mus.27091 (https://pubmed.ncbi.nlm.nih.gov/33063909/). 26.  Schwab M. E. (2004). Nogo and axon regeneration. Current opinion in neurobiology, 14(1), 118–124. https://doi.org/10.1016/j.conb.2004.01.004 (https://pubmed.ncbi.nlm.nih.gov/15018947/). 27.  Shneider, N. A., Harms, M. B., Korobeynikov, V. A., Rifai, O. M., Hoover, B. N., Harrington, E. A., Aziz-Zaman, S., Singleton, J., Jamil, A., Madan, V. R., Lee, I., Andrews, J. A., Smiley, R. M., Alam, M. M., Black, L. E., Shin, M., Watts, J. K., Walk, D., Newman, D., Pascuzzi, R. M., … Bennett, C. F. (2025). Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series. Lancet (London, England), 405(10494), 2075–2086. https://doi.org/10.1016/S0140-6736(25)00513-6 (https://pubmed.ncbi.nlm.nih.gov/40414239/). 28.  Stocchi, F., Bravi, D., Emmi, A., & Antonini, A. (2024). Parkinson disease therapy: current strategies and future research priorities. Nature reviews. Neurology, 20(12), 695–707. https://doi.org/10.1038/s41582-024-01034-x (https://pubmed.ncbi.nlm.nih.gov/39496848/).

#DTalk #Buchtipp #DNEWS24 #SandraEifert #longevity Frauen leben nicht nur länger als Männer, sie #altern auch auf ihre ganz eigene Weise. In ihrem neuen Buch erklärt #Herzspezialistin Prof. Dr. med. Sandra Eifert mit viel Einfühlungsvermögen, welche Faktoren den weiblichen #Alterungsprozess prägen – und wie jede Frau selbst dazu beitragen kann, ihn zu verlangsamen.

Sebastian spricht mit Jasmina Eifert über Incels – Männer, die sich selbst als „involuntary celibate“ bezeichnen, also unfreiwillig sexlos. Hier entwickelte sich eine radikale, frauenfeindliche Bewegung, die online Hass sät und in mehreren Fällen realen Terror verübt hat. Jasmina erklärt … Weiterlesen → The post Peinlich. Gefährlich. Incel – ein Gespräch mit Jasmina Eifert first appeared on Bartocast.

In der Türkei regiert zunehmend Willkür. Präsident Recep Tayyip Erdoğan nutzt Gerichte als Waffe gegen die Opposition und versucht so, seine Macht zu sichern. Das wird Folgen haben - nicht nur für die Türkei, sondern auch für Deutschland und Europa. Ein Kommentar von Memet Kilic www.deutschlandfunkkultur.de, Politisches Feuilleton

The clearing price of optionality in the market is impacted by a myriad of factors. To be sure, the economy and corporate profit cycle, the stance of monetary policy and geopolitical risk all matter. Flows in the derivatives markets are also of consequence as they impact the environment for supply and demand. And in this context, it was excellent to welcome Benn Eifert, Founder and Managing Partner of QVR Advisors, back to the Alpha Exchange.Benn brings a data-driven lens to today's complex volatility markets, and in this conversation, he discusses the unintended consequences of crowded risk-managed option strategies, such as buffer ETFs and overwriting. We explore how structural flows have drained the volatility risk premium, especially from the front end of the curve where the flow has especially been one way, leading to substantial optionality being sold into the marketplace. Benn states that since 2012, the VRP has largely vanished, leaving the returns to owning short-dated straddles actually positive since then. For risk-managed ETFs, the implications are unfavorable as many of these strategies often reduce beta without providing meaningful downside protection, results that are posted on the QVR website. From Benn's perspective, even for a large and liquid options complex like the S&P 500, the sheer volume of capital chasing the same trade is distorting expected returns.We finish the conversation by exploring the evolution of QVR's trade implementation and risk management practices. Here, Benn shares that the listed options market has become a focal point relative to years ago when OTC products transacted bi-laterally with large banks were of greater importance. The approach now leans into technology and seeking to exit and enter trades more passively, with a market-making approach.I hope you enjoy this episode of the Alpha Exchange, my conversation with Benn Eifert.

Back on the Cboe floor, Cem Karsan sits down with Benn Eifert to trace the fault lines shaping today's volatility regime. They dig into why market structure, not just macro, is driving outcomes... from the reflexive cycles of implied vol to the growing influence of structured product flows and zero-day options. With correlations breaking down and dispersion rising, Benn makes the case that path matters more than magnitude. It's a conversation about what happens when liquidity fragments, when the Fed can't step in, and when legacy playbooks stop working. Quietly technical, deeply contextual, this one rewards a careful listen.-----50 YEARS OF TREND FOLLOWING BOOK AND BEHIND-THE-SCENES VIDEO FOR ACCREDITED INVESTORS - CLICK HERE-----Follow Niels on Twitter, LinkedIn, YouTube or via the TTU website.IT's TRUE ? – most CIO's read 50+ books each year – get your FREE copy of the Ultimate Guide to the Best Investment Books ever written here.And you can get a free copy of my latest book “Ten Reasons to Add Trend Following to Your Portfolio” here.Learn more about the Trend Barometer here.Send your questions to info@toptradersunplugged.comAnd please share this episode with a like-minded friend and leave an honest Rating & Review on iTunes or Spotify so more people can discover the podcast.Follow Cem on Twitter.Episode TimeStamps: 00:11 - Introduction... setting the stage03:01 - Understanding Options and Market Dynamics09:47 - Market Dynamics and the Role of Administration11:41 - Market Volatility and Structural Changes in Trading19:00 - The Impact of Structural Changes on Market Volume26:13 - Understanding Market Dynamics and Asset Allocation30:23 - The Impact of Interest Rates on Investment Strategies34:21 - Understanding Zero DTE Options and Their Market Impact39:50 - Economic Outlook: Tariffs and Interest RatesCopyright © 2024 – CMC AG – All Rights Reserved----PLUS: Whenever you're ready... here are 3 ways I can help you in your investment Journey:1. eBooks that cover key topics that you need to know about In my eBooks, I...

Eifert János az Eifert Borház borász/tulajdonosa látogatott el hozzánk a Kunsági Borvidékről.

Markus Schär, Eifert nach den Gaben des Geistes

In this episode, Benn Eifert joins the show to discuss derivative & volatility strategies, the biggest derivatives misconceptions, and flaws with Stephen Miran's tariff arguments. We also delve into volatility risk under the Trump administration, how to think about VIX percentage moves, and much more. Enjoy! __ Follow Benn Eifert: https://x.com/bennpeifert Follow Felix: https://x.com/fejau_inc Follow Forward Guidance: https://twitter.com/ForwardGuidance Follow Blockworks: https://twitter.com/Blockworks_ Forward Guidance Newsletter: https://blockworks.co/newsletter/forwardguidance Forward Guidance Telegram: https://t.me/+nSVVTQITWSdiYTIx — Forward Guidance Audience Survey: https://forward-guidance.beehiiv.com/forms/109bcbf7-0948-43b8-be8d-5390a5198125 — Join us at Digital Asset Summit 2025 March 18th - 20th. USE CODE FG10 FOR 10% OFF general admission! https://blockworks.co/event/digital-asset-summit-2025-new-york __ SKALE is the next evolution in Layer 1 blockchains with a gas-free invisible user experience, instant finality, high speed, and robust security. SKALE is built different as it allows for limitless scalability and has already saved its 46 Million users over $9 Billion in gas fees. SKALE is high-performance and cost-effective, making it ideal for compute-intensive applications like AI, gaming, and consumer-facing dApps. Learn more at skale.space and stay up to date with the gas-free invisible blockchain on X at @skalenetwork — Timestamps: (00:00) Introduction (01:32) Understanding Volatility-Focused Hedge Funds (04:12) Tools and Strategies in Volatility Trading (11:21) The Rise of Derivative-Based ETFs (19:03) Skale Ad (19:27) The Rise of Derivative-Based ETFs (Con't) (27:15) Risks and Misconceptions in Retail Options Trading (32:06) Skale Ad (32:36) Risks and Misconceptions in Retail Options Trading (Con't) (37:09) Options Trading (41:07) Implied Probabilities and Market Misconceptions (44:17) The Reality of Options Pricing Models (47:06) Impact of Derivatives on the Market (57:47) Navigating Volatility in the Trump Era (01:01:01) Debating the Merits of Tariffs __ Disclaimer: Nothing discussed on Forward Guidance should be considered as investment advice. Please always do your own research & speak to a financial advisor before thinking about, thinking about putting your money into these crazy markets.

Sandra Eifert ist Leiterin einer der größten europäischen Frauensprechstunden. Die Oberärztin am Herzzentrum Leipzig hat viele Jahre in der Transplantationsmedizin gearbeitet. Inzwischen hat sie sich in der Gendermedizin spezialisiert und dort ihre Sichtweise auf das Herz vertieft. Zusammen mit der Ärztin Suzann Kirschner-Brouns hat sie nun ein Buch herausgegeben mit dem Titel "Herzsprechstunde – Warum das WEIBLICHE HERZ anders ist und wie es gesund bleibt". Ihre These: "Das Frauenherz ist kein kleines Männerherz". Geschlechterunterschiede in der Medizin, so erfährt man im Buch, wurden über viele Jahre vernachlässigt. Die Gendermedizin ist wichtig geworden, besonders bei Herz-Kreislauf-Erkrankungen, aber auch in anderen medizinischen Bereichen. Ein hochkomplexes Thema, über das Sandra Eifert mit Beate Scheibe in "NDR Kultur à la carte" spricht.

Es ist ein bisschen ruhiger geworden um "Redox-Flow-Batterien", so will man in Deutschland meinen. Gründe dafür gibt es genug: Die europäischen Stromnetze zählen weiterhin zu den stabilsten der Welt und werden länderübergreifend immer integrierter gedacht. Auch wenn wir Europäer davon nichts spüren, so sind Redox-Flow-Batterien in anderen Kontinenten doch gefragter als jemals zuvor.

Prof. Dr. med. Sandra Eifert ist eine der wenigen Herzchirurginnen in Deutschland. Was Gendermedizin bedeutet und warum Frauenherzen anders als Männerherzen sind und auch anders behandelt werden müssen, darüber spricht sie auf der Blauen Couch.

Woohoo! We're back! In the first guest episode of From the Dog's Perspective podcast Season #2, I have the privilege to chat with a talented dog trainer, competitor, and all-around lovely person — OneMind Dogs Coach Anna Eifert, from Hungary.Anna is an active international traveler and explorer, passionate about sharing the OneMind Dogs method wherever she goes. She is known for teaching and competing in agility internationally, not only with her border collies but also with her miniature bullterrier!Listen to her insightful stories, learnings, and tips for all dog and dog agility lovers!  Learn more about Anna: Her coach profileFacebook pageYouTube ChannelVisit OneMind Dogs and learn more about the dog's perspective!Do you have a new dog at home? Or do you want to start it all over?Start the OneMind Dogs puppy training program today and get the OneMind Dogs team's support. To get the podcast newsletter, sign up here!

Ellis Eifert joins Mike for the 100th episode!  Ellis owns Eifert Law and specializes in estate planning.  On episode 53, he goes into depth discussing a trust and putting your home in a trust. But on this episode Mike and Ellis discuss local rafting, hunting, 4h pigs, and including the kids on the adventures.  They also hit on a little bit of estate planning!

Ulrike Timmwww.deutschlandfunkkultur.de, Im GesprächDirekter Link zur Audiodatei

Stefan Brink war kürzlich zu Gast beim Europarat in Straßburg mit einem Vortrag zum Datenschutz und zum Schutz der Privatsphäre bei Anti-Doping-Maßnahmen. Im Gespräch mit Niko Härting erläutert Stefan Brink die Rolle und Funktion des Europarats und berichtet über die eklatanten Eingriffe in Persönlichkeitsrechte der Leistungssportler, die im Zeichen des Kampfes für einen „sauberen Sport“ zu deren beruflichem Alltag gehören. All dies auf der Basis – angeblich – „freiwilliger“ Einwilligungen der Sportlerinnen und Sportler. Ab Minute 12:20 : Martin Eifert, Professor für öffentliches Recht und Verwaltungsrecht an der Humboldt-Uni Berlin ist seit Februar 2023 (auf Vorschlag der „Grünen“) Richter des 1. Senats des BVerfG. Im April erschien in der JuristenZeitung ein Aufsatz, den Eifert gemeinsam mit Nora Wienfort verfasst hat (JZ 2023, 270 ff.). Es geht um „Hassrede als Gefährdung der verfassungsrechtlich geschützten offenen Kommunikation unter Freien und Gleichen“. In diesem Aufsatz wird versucht, die Meinungsfreiheit (Art. 5 Abs. 1 GG) durch einen „Schutz der Entschließungsfreiheit zur sozialen Exponierung“ als Ausprägung des Allgemeinen Persönlichkeitsrechts zu ergänzen, um auf diese Weise „Einschüchterungseffekte“ von „Hassrede“ verfassungsrechtlich zu erfassen. Dies läuft auf eine Einschränkung der Meinungsfreiheit im Zeichen des Schutzes des „öffentlichen Diskurses“ hinaus und liegt auf einer Linie mit der Rhetorik, die man seit dem Netzwerkdurchsetzungsgesetz (NetzDG) verwendet, um gegen „lawful but awful speech“ vorzugehen. Tendenziell schränkt man die Meinungsfreiheit lautstarker Minderheiten im Interesse des ungestörten „öffentlichen Diskurses“ der Mehrheit ein. Ab Minute 30:10 : Ferdinand Kirchhof, emeritierter Professor für öffentliches Recht und von 2010 bis 2018 Vizepräsident des BVerfG, hat sich in der NJW unlängst mit dem „Wirkungsbereich des Grundrechts auf Meinungsfreiheit“ befasst (NJW 2023, 1922 ff.). Kirchhof ist ein Konservativer. Anders als der linksliberale Eifert sieht er die Meinungsfreiheit weniger bedroht durch „Hassrede“ als durch „Zensur aus den Reihen der Gesellschaft“, „Political Correctness“, „Cancel Culture“ und das, was Kirchhof unter „Wokeness“ versteht. Ähnlich wie Eifert sieht Kirchhof die Meinungsfreiheit weniger durch den Staat bedroht als durch „durchsetzungsstarke Minderheiten“. Ähnlich wie Eifert beklagt er einen unzureichenden Schutz des „Publikums“ vor lautstarken Minderheiten. Die Ähnlichkeit des Denkens von Eifert und Kirchhoff ist frappierend.

As we navigate an increasingly interconnected world, the technological disruption we face is inescapable, particularly with the Internet of Things (IoT) at the core of the conversation. IoT promises innovation and optimization, but the reality is that it's a vast landscape that is constantly evolving and often misunderstood. To understand its potential and challenges, DisruptED host, Ron Stefanski, sits down with an expert on the subject, Dave Eifert, Senior Business Development Manager at Phoenix Contact USA.In this episode, they unravel the journey of IoT, its successes, its failures, and its promise for the future. They discuss:The initial perception and excitement around IoTThe subsequent disillusionment due to high failure rates of IoT initiativesThe shift in approach to focus on specific business problemsThe pivotal role of data sharing in making IoT workReal-world success stories and the discovery of 'information in the shadows'.Dave Eifert comes with an extensive background in tech. An engineering and management dual degree holder, Eifert has spent his entire career working in the electrical industry, always gravitating toward high-tech, cutting-edge developments. He joined Phoenix Contact 18 years ago and has held various roles. Eifert has spent the last 18 to 24 months as the business development manager for Phoenix Contact USA for IIoT, navigating the fascinating yet complex IoT landscape.

One area that continues to redefine possibilities in technology is IoT disruption. With an estimated 30 billion IoT devices expected to be in use by 2025, the stakes are high, and the potential for transformation is immense. However, with this surge in IoT adoption, there's a growing concern about the successful implementation of these technologies, with studies suggesting that up to 75% of IoT projects fail. So, how can businesses navigate this complex terrain and harness the power of IoT effectively? Who are the disrupters willing to go beyond the norm?Phoenix Contact, an electrical engineering and automation solutions provider, is one company leading in IoT disruption. Phoenix Contact received the 2023 Governor's Award for Environmental Excellence (GAEE) for its innovative rooftop solar project. The award, presented by the Pennsylvania Department of Environmental Protection, recognizes the company's 961-kilowatt solar array that caters to about 30% of the energy needs at its U.S. headquarters. And it is that blend of providing solutions with sustainability in mind that disrupts the industry and creates positive new trends.In the latest episode of DisruptED, host Ron J Stefanski engaged with Dave Eifert, Senior Business Development Manager at Phoenix Contact USA, to talk about the challenges and opportunities inherent in the world of IoT, with a focus on the industrial application of these technologies.Key points from the episode include:• The importance of starting small with IoT projects, focusing on well-defined processes or issues, and using IoT as a toolbox to solve specific business problems• The potential of IoT data to provide unexpected insights and benefits when viewed from different perspectives, highlighting the importance of data sharing• The critical role of sustainability in the context of IoT, with a focus on the need for cross-functional, open, shared data sourcesDave Eifert, an engineering and management graduate, has spent his entire career in tech. Over the years, he has worked in various roles at Phoenix Contact, including product sales engineer and automation sales, before transitioning into his current role as the business development manager for IIoT. With a keen interest in high-tech, cutting-edge technologies, Eifert brings knowledge and experience to the dynamic world of IoT.

Join Dave Eifert of Phoenix Contact as we talk about how to use the data you're collecting.We'll talk about the following:1) What is Sustainability?2) What does a Data-Driven Enterprise look like?3) Who will lead the charge into the next generation of solutions?A big thank you to Phoenix Contact USA for sponsoring this theme and your continued support of the community.Manufacturing Hub Episode 103. Connect with UsDave EifertVlad RomanovDave GriffithManufacturing HubSolisPLCProfit by Design#manufacturing #automation #iot #engineering #digitaltransformation

Heute mit Samira und Robert. In der Nacht zu Freitag ist Michael Eifert eine Box-Sensation in Kanada gelungen: Der SES-Boxer hat den Ex-Weltmeister Jean Pascal nach zwölf Runden besiegt. Eifert gewann im kanadischen Laval mit 117-111, 115-113 und 118-110 einstimmig nach Punkten. Der 25-jährige Deutsche startete leichtfüßig und mit schnellen Händen in das Duell. Der … „Boxpodcast 402 – Sensation: Michael Eifert besiegt Jean Pascal und ist IBF-Herausforderer“ weiterlesen

Heute mit Samira, Robert, Michael Eifert und Ali Celik. In der Nacht zu Freitag steigt SES-Boxer Michael Eifert in einem IBF-Ausscheidungskampf gegen Ex-Weltmeister Jean Pascal in den Ring. Der 25-jährige Halbschwergewichtler steigt im Place Bell im kanadischen Laval zum größten Kampf seiner bisherigen Karriere in den Ring. Vorab sprachen Samira und Robert vom Boxpodcast mit … „Boxpodcast 401 – Interview mit Michael Eifert: „Auf so eine Chance wartet man als Boxer!““ weiterlesen

Amanda Galle is set to face Mexican pugilist Lorena Cruz Aispuro on the Pascal-Eifert undercard in Laval, Québec, next March 16th. I took a moment with her to chat about her preparation for this fight. I also asked her to answer some fun questions in order to know her better. You like my stuff? Please subscribe to my channel and my social network accounts. Everything is available here : linktr.ee/120secondes. Enjoy! Marie-Eve

¿Sabías que una de las herramientas más eficaces para liberar estrés y mejorar tu salud mental es gratuita? En este episodio hablamos de todos los beneficios increíbles y que probablemente desconozcas de la escritura reflexiva y te vamos a ayudar a ponerte en el camino para que puedas empezar a disfrutar de esta práctica terapéutica. Referencias bibliográficas: ·Baikie, K., & Wilhelm, K. (2005). Emotional and physical health benefits of expressive writing. Advances in Psychiatric Treatment, 11(5), 338-346. · Ford, B. Q., Lam, P., John, O. P., & Mauss, I. B. (2018). The psychological health benefits of accepting negative emotions and thoughts: Laboratory, diary, and longitudinal evidence. Journal of Personality and Social Psychology, 115(6), 1075-1092. · Forsyth, J. P., & Eifert, G. H. (2016). The Mindfulness & Acceptance Workbook for Anxiety: A Guide to Breaking Free from Anxiety, Phobias & Worry Using Acceptance & Commitment Therapy. Oakland, CA: New Harbinger Publications. · Fredrickson, B. (2010). Positivity: Groundbreaking research reveals how to release your inner optimist and thrive. Richmond: Oneworld. · Krentzman, A. R., Hoeppner, B. B., Hoeppner, S. S., & Barnett, N. P. (2022). Development, feasibility, acceptability, and impact of a positive psychology journaling intervention to support addiction recovery. The Journal of Positive Psychology, 1-19. · Mims, R. (2015). Military veteran use of visual journaling during recovery. Journal of Poetry Therapy, 28(2), 99-111. · Newman, K. (2020). How journaling can help you in hard times. Retrieved September 2, 2022, from https://greatergood.berkeley.edu/article/item/how_journaling_can_help_you_in_hard_times · Sohal, M., Singh, P., Dhillon, B. S., & Gill, H. S. (2022). Efficacy of journaling in the management of mental illness: A systematic review and meta-analysis. Family Medicine and Community Health, 10(1). · Tartakovsky, M. (2022, February 22). 15 benefits of journaling and tips for getting started. Retrieved September 2, 2022, from https://www.healthline.com/health/benefits-of-journaling · WebMD.com. (2021). How journaling can help ease anxiety and encourage healing. Retrieved September 2, 2022, from https://www.webmd.com/mental-health/mental-health-benefits-of-journalingMentioned in this episode:¿Qué es lo que dice la Biblia sobre el amor? ❤️Descúbrelo en la charla “Lo que el Antiguo y Nuevo Testamento nos enseñan sobre el amor” con Fr. Sergio Serrano, host del podcast “La Biblia en un Año”. La cita es el 9 de febrero a las 9:00A.M (hora CDMX). Regístrate al Zoom en: Charla Fray Sergio Serrano¿Te has preguntado por qué millones de personas de todo el mundo visitan la gruta de Lourdes en Francia cada año?Bosco Films te lo cuenta en su más reciente película LOURDES. Si vives en Estados Unidos o tienes un tío, amigo, conocido que viva por allá, no se pueden perder la oportunidad de verla el próximo jueves 9 de febrero en cines. Será la única fecha en que se exhibirá subtitulada al español, así que corre a dar click para reservar los boletos en tu sala de preferencia… ¡Ah! Y no olvides compartirla con tus conocidos.Lourdes

We begin with news that pioneering boxer Christy Martin was presented with the "Boxing Legend Award" and then discuss fights involving Sulem Urbina, Giovanni D´Antoni, Josh Stokes and Jean Pascal, before concluding with a note on the recent passing of Steve Smoger, one of the most respected and in-demand referees in the sport. Watch live on www.TalkinFight.com and more episodes on YouTube.com/c/TalkinFight  @DAZNBoxing   @foxsports   @espn   @TheWorldofBoxing   @YourBoxingGuide   @MatchroomBoxing   @toprank   @PremierBoxingChampions   @mayweatherpromo   @GoldenBoyBoxing   @BTSport   @BTSportBoxing   @skysportsboxing   @boxxer9874   @draftkings   @ProbellumBoxing   @QueensberryPromotions   @SalitaPromotions   @ringiqboxingtalk   @ringside4587  #boxingnews #talkinfight #boxen247 #wba #wbc #ibf #wbo #ibo #ubo Featured today: Aureliano Sosa, Cesar Francis, Christy Martin, Dave Schuster, Deni Auclair, Ed Post, Jeanette Salazar, katie taylor, Kevin Moley, Michael Pickford, Ricky Gonzalez, Ring 8, Ron Borges, Timothy Mertens, Alejandro Luis Silva, Andy Dominguez, Anthony Sims Jr, Anthony Todd, Decarlo Perez, Elon de Jesus, Indeya Smith, Jesus Arturo Guzman, Marvin Solano, NADIM SALLOUM, Sulem Urbina, D´Antoni vs. Riccardo, Giovanni D´Antoni, Joshua Riccardo, UBO, Universal Boxing Organization, BCB Promotions, Josh Stokes, Jean Pascal, Michael Eifert, Pascal vs. Eifert, and Steve Smoger.

Helen Eifert is the Founder, Manager, Player and Captain of the Arizona Sidewinders, a team in the Western Ultimate League. She was an early organizer and team representative of League Development Committee of the Western Ultimate League as well. The Arizona Sidewinders are the first professional ultimate team in the state of Arizona! Helen is truly a trailblazer and was a gem to chat with. Enjoy our episode!Follow the Sidewinders on Twitter, Instagram, Facebook, and their websiteCheck out the Sidewinders STORE and use SUMMER5 for $5 off all women's sports apparel until September 22!Watch this episode on YouTubeSign up for the She Plays newsletter!Follow She Plays on Instagram, Twitter, Facebook, and onlineCheck out our other podcasts: Sports Break and The Warm Up!

Summer's nearly over and class is definitely back in session for this episode, as we're about to get schooled on options and trying to separate the scams from the science. This week we're delivering the long-awaited episode with Dr. Benn Eifert, a Derivative appointed Jedi of Volatility from QVR Advisors, and Dr. David Rhoiney, who overcame being homeless to become a robotic surgeon who is learning the financial ropes and sharing his journey on Twitter from Surgifi. David has questions: what do you do with all the Greeks, can't you tell a trend is starting by analyzing options volume, what about skew? And Benn has the answers in this entertaining 70-minute lively back and forth. They touch on being an independent thinker like David to come to your own investing conclusions, whether the options courses out there are knowingly selling lies, or more innocently peddling luck and lottery tickets. Why Black Scholes doesn't really do anything except normalize prices…meaning there's no secret math that lets you ‘figure out' options. How trend following only works 25% of the time, Nancy Pelosi's high fee LEAPS trades, Nassim Taleb's tail hedges, why it counter-intuitively makes sense to add a losing asset to your portfolio, and so much more! Plus, we discuss should retail investors walk away from options and how not to get caught up in the index funds cult — SEND IT! Chapters: 00:00-01:54 = Intro 01:55-21:52 = Greeks, Bid/Ask, a Tech Stack… where do you even get started? 21:53-39:36 = Implied Volatility doesn't tell you anything about what to do 39:37-58:36 = Someone selling you a trade based on skew = run the other way 58:37-01:12:15 = Pelosi's LEAPS? Taleb's Tail Hedges? Why add a losing asset? 01:12:16-01:17:22 = Hottest takes: just walk away from Options, steak is overrated, and the Devil's nipples From the episode: Benn Eifert's Tweet on adding Tail Risk Surgifi's newsletter Follow along with Benn Eifert on Twitter @bennpeifert and David Rhoiney on Twitter @FiSurgi. For more information on QVR Advisors check out their website www.qvradvisors.com and for more on Surgifi visit surgifi.com Don't forget to subscribe to The Derivative, follow us on Twitter at @rcmAlts and our host Jeff at @AttainCap2, or LinkedIn , and Facebook, and sign-up for our blog digest. Disclaimer: This podcast is provided for informational purposes only and should not be relied upon as legal, business, or tax advice. All opinions expressed by podcast participants are solely their own opinions and do not necessarily reflect the opinions of RCM Alternatives, their affiliates, or companies featured. Due to industry regulations, participants on this podcast are instructed not to make specific trade recommendations, nor reference past or potential profits. And listeners are reminded that managed futures, commodity trading, and other alternative investments are complex and carry a risk of substantial losses. As such, they are not suitable for all investors. For more information, visit www.rcmalternatives.com/disclaimer

When people think about the market mania we recently experienced, the most glaring thing that comes to mind is the meme stocks. In early 2021, the huge moves in names like AMC and GameStop exemplified this new Robinhood, r/WSB, crypto world. But there were activities much more egregious than some retail traders buying odd lots on Robinhood. Serious, professional investors and traders lost huge sums of money giving out unsecured loans to crypto hedge funds like 3AC, which then proceeded to incinerate their money. In other words, lots of people, with a range of sophistication, threw out some basics of risk management wholesale. On this episode of the podcast, we spoke with Benn Eifrt, founder and CIO at the boutique volatility hedge fund QVR Advisors, about how manias happen, and the big lessons everyone should learn from the market over the last two years.See omnystudio.com/listener for privacy information.

In this episode of Forward Guidance Benn Eifert, Founder & CIO of QVR Advisors joins the show for a deep dive discussion on all things volatility. As markets are all down year to date, many investors have been surprised with the orderly selling and lack of increase in the VIX. Luckily we have Benn on the show to share the role of put options in this market, wether or not macro matters for volatility traders and volatility at both the single stock and index level. We also discussed the past two years of stimulus induced retail options trading, how market structure has evolved, the best hedges for a slowly falling market and when we could expect a market bottom. To hear that, you'll have to tune in! -- Follow Benn Eifert on Twitter https://twitter.com/bennpeifert Follow Jack on Twitter https://twitter.com/JackFarley96 Follow Blockworks on Twitter https://twitter.com/Blockworks_ -- Get top market insights and the latest in crypto news. Subscribe to Blockworks Daily Newsletter: https://blockworks.co/newsletter/ -- (00:00) Introduction (00:15) Background (05:10) The Rise (And Fall?) Of Retails Options Traders (08:50) Put Options' Role In This Year's Viscous Sell-Off (13:57) The VIX (19:29) The Pricing of Tail Risk (24:32) Best Hedges For A Slowly Falling Market (28:00) Single-Stock Volatility (33:34) How Responsive Are Options Market Makers? (39:58) Credit and Treasury Volatility (48:11) Options Expiry ("OpEx") (55:35) Common Options Mistakes (1:01:00) The Macro (1:05:50) Does The VIX Have To Spike In Order For Stocks To Bottom? -- Disclaimer: Nothing discussed on Forward Guidance should be considered as investment advice. Please always do your own research & speak to a financial advisor before thinking about, thinking about putting your money into these crazy markets.

Heute empfangen wir die erste Sozialdezernentin Bottrops bei uns an den Mikros, denn Karen Alexius-Eifert ist unser Gast. Die Leiterin des Sozialamtes ist die erste Frau in der Bottroper Stadtspitze und das war Grund genug sie zu uns ins Studio einzuladen. Ok, und weil sie gut aussieht. Bei einem Bottroper Bier haben wir mit ihr über ihren Werdegang geplaudert und so die ein oder andere interessante Sache über Karen erfahren. Wie hat sie es soweit an die Stadtspitze geschafft und war das schon immer ihr Masterplan? Neben dem Bottroper Alltagswahnsinn und einer tierischen Horrorstory die es in sich hat, war natürlich auch wieder "Wieviel Bottrop bist DU?" dabei, was zum ersten Mal von einem Hörer gestellt wurde. Wie das ausgegangen ist und warum man sich manchmal viel zu wenig Gedanken über die ganz kleinen Lebenwesen macht hört ihr heute bei uns im Bottcast. Viel Spaß.

Ellis discusses estate planning with Mike.  For more information contact Ellis at Eifert Law Firm, 409 S Jackson St, Moscow ID.

What do people usually fear in life? How do our fears affect us? And what can we do about them? Join me in this week's episode as I explore the nature of fear and its counterpart, avoidance, as well as providing a framework to stop fear from boxing us in in our lives. ACT Values List: https://www.actmindfully.com.au/wp-content/uploads/2019/07/Values_Checklist_-_Russ_Harris.pdf References American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (Vol. 5). American Psychiatric Association. Dyer, W. (2005). The power of intention. Hay House. Forsyth, J. P., & Eifert, G. H. (2008). The mindfulness & acceptance workbook for anxiety: A guide to breaking free from anxiety, phobias, and worry using Acceptance and Commitment Therapy. New Harbinger.

On today's episode, Hari Krishnan is joined today by Benn Eifert, to discuss running a volatility fund, the benefits that Benn gets from using Twitter, how to effectively serve clients as a volatility trader, the drawbacks of hedging via ETFs, monitoring market flows, the popularity of short-dated options, implied volatility versus realised volatility, how correlations change over time, balancing family-life with managing a fund, and the new normalisation of working from home. In this episode, we discuss: A behind the scenes look at running a volatility fund How to use Twitter as an investor Bringing value to clients as a volatility trader Hedging via ETFs Market flows Options Implied volatility Finding a good work & life balance Follow Niels on https://twitter.com/toptraderslive (Twitter), https://www.linkedin.com/in/nielskaastruplarsen (LinkedIn), https://www.youtube.com/user/toptraderslive (YouTube) or via the https://www.toptradersunplugged.com/ (TTU website). IT's TRUE

Was können wir für die Biene tun? Warum ist es wichtig, sich um Bienen zu kümmern? Außerdem erzählt Tina was ihre Tochter einmal mit der Biene erlebt hat und wie ihr noch mehr über Tina und ihren Automaten lernen könnt Hier findet ihr Christina: Instagram: @christinagrubereifert ([https://www.instagram.com/christinagrubereifert/](https://www.instagram.com/christinagrubereifert/)) Tinautomat: @tinautomat ([https://www.instagram.com/tinautomat/](https://www.instagram.com/tinautomat/)) Homepage: [https://www.christina-grubereifert.com/](https://www.christina-grubereifert.com/) Hannes: @rock.it.raketenstart

Was hat Nachhaltigkeit mit Bienen zu tun? Warum sollten wir gut mit der Erde umgehen? Was bedeutet das für die Welt? Darum geht es in Teil 1 des Interviews mit Christina Gruber-Eifert. Morgen folgt Teil 2. Hier findet ihr Christina: Instagram: @christinagrubereifert (https://www.instagram.com/christinagrubereifert/) Homepage: https://www.christina-grubereifert.com/ Hannes: @rock.it.raketenstart

Whether stemming from a recession, a policy shock, a terrorist attack, or a global pandemic, financial markets periodically go through major selloffs. It has always been this way. Euphoria eventually leads to panic, every time. Another way to look at these crashes is through the lens of volatility (and its commensurate rise), which has become a fundamental component of investment decisions. As time goes by, innovations can (and will) suppress volatility and can sometimes give the impression that risk has been eliminated, but that is always a fool's dream. Eventually the piper must be paid. Our guests this week were Benn Eifert (Founder & CIO) and Scott Maidel (Head of Business Development), of QVR Advisors, a boutique asset manager that specializes in strategies seeking to profit from volatility and all its downstream effects – including attempts to suppress it. We covered: How markets fundamentally changed following the Great Financial Crisis Call overwriting – the favorite strategy of yield-thirsty institutions Why ‘selling vol' is too broad a term and has all but lost its meaning Everybody wants protection – reflexivity and the options tail that wags the equity dog The behemoth equity hedged strategy that now moves the market at the end of every quarter “Gradually, then suddenly” – the nature of volatility Gamma & Vanna – the second-order ‘Greeks' and their outsized influence in short-term moves Execution is key – don't trade against the Flash Boys Buying what you don't want to build Systematic vs Quant Benn and Scott also described in detail QVR's two main lines of business – absolute return and tailored solutions – providing insight into their processes and competitive advantages. We also discussed the distinct nature of different market crashes, trade monetization, rebalancing, and much more. It was a fascinating conversation and a true lesson on the current structure of equity markets. Thank you for watching and listening. See you next week.   This is “ReSolve's Riffs” – live on YouTube every Friday afternoon to debate the most relevant investment topics of the day, hosted by Adam Butler, Mike Philbrick and Rodrigo Gordillo of ReSolve Global* and Richard Laterman of ReSolve Asset Management.   *ReSolve Global refers to ReSolve Asset Management SEZC (Cayman) which is registered with the Commodity Futures Trading Commission as a commodity trading advisor and commodity pool operator. This registration is administered through the National Futures Association (“NFA”). Further, ReSolve Global is a registered person with the Cayman Islands Monetary Authority.    

So auch ihr, da ihr nach geistlichen Gaben eifert, so strebt danach, dass ihr überreich seid zur Erbauung der Gemeinde. 1.Kor. 14,12 Eifert aber um die größeren Gnadengaben! Und einen Weg noch weit darüber hinaus zeige ich euch... 1.Kor. 12,31 ELB

Milyen volt a Nyári BorMozi (2021.06.) erről is beszélgetünk Mc Spirittel és közben Generosát kortyolunk az Eifert Borháztól. Az első részben Generosa 2020-as kortyolunk majd a második részben beszélgetünk telefonon a Generosa szőlőfajtáról, Eifert Jánossal és 2019-es (fahordós) Eifert Generosát kóstolunk.

Volatility skews and options can play an important role in global markets. Dr Benn Eifert's QVR Advisors offers quantitative strategies on options products. He joins Ken, Paul, and James to talk about the rising use of options by retail traders.Support this show http://supporter.acast.com/the-bip-show. See acast.com/privacy for privacy and opt-out information.

Benn Eifert is the managing member and CIO of QVR Advisors, a quantitatively-driven, options-and volatility-focused investment manager. QVR helps institutional investors navigate the highly complex derivatives market. Listen in as Benn talks to Richard about the Genesis of QVR, the evolution of the Derivatives Markets as well as how his firm adds value to clients. Benn also delves into his background, the GameStop Gamma Squeeze, Retail Activity in the Options Market and much more. To learn more about Benn please visit www.qvradvisors.com or follow him on Twitter @bennpeifert.  To learn more about Richard please visit www.thinkaen.com. Show Notes: (01:14) About Benn and QVR (03:42) Time spent at Wells Fargo, Prop Desk (04:32) The Derivatives  and the time of the Wild West, Benn explaining Derivatives versus other instruments (09:51) The shift from Over the Counter (OTC) Derivatives to Listed Derivatives (12:09) Equity Options and Retail Trading (13:03) Regulators and other Watch Dogs (15:32) Delving into QVR, Process Driven Advisor, U.S Allocation, Different Asset Classes (18:29) Recurring Thematic Dislocations (22:31) AMC and GameStop, Roaring Kitty (27:35) Gamma Squeeze (28:32) Implied Volatility and how it impacts the markets (30:35) Melvin Capital and what exactly happened (33:32) AQR and its hunt for dislocations (34:35) What led Benn to start a fund, setting up his Team (37:12) Talking about his Popular "Junior Analyst" Interview Questions (39:05) It all comes down to Supply and Demand (42:57) Learning from mistakes, unwinding trades (43:24) Cycling in San Francisco and the Cycling Jersey (44:00) Peleton, Family Life and Closing Remarks  

TOPICS:- Chris Boswell/Matt McCrane- Antonio Brown- Injury report- Keith Butler Learn more about your ad choices. Visit podcastchoices.com/adchoices

James Rapien talks with John Ross on today's podcast. Plus, Tyler Eifert talks with the media and Indianapolis Colts' head coach Frank Reich discusses Andrew Luck's health, Sunday's game against the Bengals and more.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

James Rapien talks with Tyler Eifert about his health and explains why him being on the PUP list to start camp isn't a huge deal. Plus, Jeff Driskel and Nick Vigil are guests on today's Locked on Bengals podcast.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

James Rapien talks with Jim Owczarski to get the latest on Tyler Eifert. He also talks with Vinny Rey, Darqueze Dennard and William Jackson III on today's podcast.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

James Rapien discusses the latest Tyler Eifert news, training camp and more national predictions for the Bengals on today's podcast. Learn more about your ad choices. Visit podcastchoices.com/adchoices

On today's podcast James Rapien talks about a reality the Bengals face if they let Tyler Eifert leave in free agency and gives his thoughts on John Ross' latest comments.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

On today's podcast James Rapien says the Bengals should consider using the franchise tag on Tyler Eifert. Plus, Bill Polian and Tony Pike discuss quarterbacks in the 2018 NFL Draft.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

On today's podcast Pacman Jones defends Marvin Lewis, James Rapien is joined by Jim Owczarski of Cincinnati.com and James says he wants the Bengals to keep Tyler Eifert.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Fantasy Doctors is a closer look at injuries as they pertain to Fantasy Sports.  We have partnered with some of the most prominent medical doctors in the country, most notably Dr. Selene Parekh (Duke University Professor & Orthopedic Surgeon).  Dr. Parekh and our physician partners analyze the injuries and discuss their expectations for the athletes recovery and return to competition.  In this week's episode we break down injuries of Olsen, Bradford, Coleman, Reed, Nelson, Prescott, Eifert, Murray, Cobb, Kelley, Graham, Burkhead, Gronk and more! Dr. Jesse Morse breaks down his top DFS plays using the FDx score and who he feels will have a big week 3 in the NFL.   *DISCLAIMER* The opinions given by TFD physicians are just that, opinions. They are based on the information available to the author at the time of publication; are general; and are not based on any formal physical assessment and/or diagnosis by the author. If you believe you may be suffering from an injury similar to one commented on by the author, do not rely on the author's advice as it may not apply to you – see a qualified physician for a full assessment, diagnosis and treatment plan.

The Fantasy Doctors is a closer look at injuries as they pertain to Fantasy Sports.  We have partnered with some of the most prominent medical doctors in the country, most notably Dr. Selene Parekh (Duke University Professor & Orthopedic Surgeon).  Dr. Parekh and our physician partners analyze the injuries and discuss their expectations for the athletes recovery and return to competition.  In this week's episode we break down injuries of Olsen, Bradford, Coleman, Reed, Nelson, Prescott, Eifert, Murray, Cobb, Kelley, Graham, Burkhead, Gronk and more! Dr. Jesse Morse breaks down his top DFS plays using the FDx score and who he feels will have a big week 3 in the NFL.   *DISCLAIMER* The opinions given by TFD physicians are just that, opinions. They are based on the information available to the author at the time of publication; are general; and are not based on any formal physical assessment and/or diagnosis by the author. If you believe you may be suffering from an injury similar to one commented on by the author, do not rely on the author's advice as it may not apply to you – see a qualified physician for a full assessment, diagnosis and treatment plan.